Erratum: Prognostic impact of complete remission with MRD negativity in patients with relapsed or refractory AML (Blood Advances (2020) 4:24 (6117-6126) DOI: 10.1182/bloodadvances.2020002811)

N. J. Short; H. Rafei; N. Daver

doi:10.1182/bloodadvances.2020004049

Erratum: Prognostic impact of complete remission with MRD negativity in patients with relapsed or refractory AML (Blood Advances (2020) 4:24 (6117-6126) DOI: 10.1182/bloodadvances.2020002811)

N. J. Short, H. Rafei, N. Daver

Leukemia

Research output: Contribution to journal › Comment/debate › peer-review

Abstract

In the center of the visual abstract, the symbols immediately to the left of both instances of "ability to proceed to HSCT,""risk of relapse,"and "overall survival"should have been arrows. The publisher apologizes for the error, which has been corrected in the published article.

Original language	English (US)
Pages (from-to)	366
Number of pages	1
Journal	Blood Advances
Volume	5
Issue number	2
DOIs	https://doi.org/10.1182/bloodadvances.2020004049
State	Published - Jan 26 2021

ASJC Scopus subject areas

Hematology

Access to Document

10.1182/bloodadvances.2020004049

Cite this

@article{41ce7e7a5ced4ff2a96a946f614ac332,

title = "Erratum: Prognostic impact of complete remission with MRD negativity in patients with relapsed or refractory AML (Blood Advances (2020) 4:24 (6117-6126) DOI: 10.1182/bloodadvances.2020002811)",

abstract = "In the center of the visual abstract, the symbols immediately to the left of both instances of {"}ability to proceed to HSCT,{"}{"}risk of relapse,{"}and {"}overall survival{"}should have been arrows. The publisher apologizes for the error, which has been corrected in the published article.",

author = "Short, {N. J.} and H. Rafei and N. Daver",

note = "Publisher Copyright: {\textcopyright} 2021 by The American Society of Hematology.",

year = "2021",

month = jan,

day = "26",

doi = "10.1182/bloodadvances.2020004049",

language = "English (US)",

volume = "5",

pages = "366",

journal = "Blood Advances",

issn = "2473-9529",

publisher = "American Society of Hematology",

number = "2",

}

TY - JOUR

T1 - Erratum

T2 - Prognostic impact of complete remission with MRD negativity in patients with relapsed or refractory AML (Blood Advances (2020) 4:24 (6117-6126) DOI: 10.1182/bloodadvances.2020002811)

AU - Short, N. J.

AU - Rafei, H.

AU - Daver, N.

PY - 2021/1/26

Y1 - 2021/1/26

N2 - In the center of the visual abstract, the symbols immediately to the left of both instances of "ability to proceed to HSCT,""risk of relapse,"and "overall survival"should have been arrows. The publisher apologizes for the error, which has been corrected in the published article.

AB - In the center of the visual abstract, the symbols immediately to the left of both instances of "ability to proceed to HSCT,""risk of relapse,"and "overall survival"should have been arrows. The publisher apologizes for the error, which has been corrected in the published article.

UR - http://www.scopus.com/inward/record.url?scp=85100233652&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85100233652&partnerID=8YFLogxK

U2 - 10.1182/bloodadvances.2020004049

DO - 10.1182/bloodadvances.2020004049

M3 - Comment/debate

C2 - 33496732

AN - SCOPUS:85100233652

SN - 2473-9529

VL - 5

SP - 366

JO - Blood Advances

JF - Blood Advances

IS - 2

ER -

Erratum: Prognostic impact of complete remission with MRD negativity in patients with relapsed or refractory AML (Blood Advances (2020) 4:24 (6117-6126) DOI: 10.1182/bloodadvances.2020002811)

Abstract

ASJC Scopus subject areas

Access to Document

Other files and links

Fingerprint

Cite this